Phio Pharmaceuticals Corp. Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Phio Pharmaceuticals Corp. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q3 2024.
  • Phio Pharmaceuticals Corp. Entity Common Stock, Shares Outstanding for the quarter ending November 14, 2024 was 1.06M shares, a 56.8% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.06M -1.39M -56.8% Nov 14, 2024 10-Q 2024-11-14
Q2 2024 861K -1.36M -61.3% Aug 2, 2024 10-Q 2024-08-14
Q1 2024 4.59M +3.44M +299% Mar 15, 2024 10-K 2024-04-01
Q3 2023 2.44M -11.2M -82.1% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 2.22M -11.4M -83.7% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 1.15M -12.4M -91.5% Mar 9, 2023 10-K 2023-03-22
Q3 2022 13.7M +133K +0.99% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 13.7M +124K +0.92% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 13.5M +3.06K +0.02% Mar 11, 2022 10-K 2022-03-22
Q3 2021 13.5M +7.75M +134% Nov 5, 2021 10-Q 2021-11-10
Q2 2021 13.5M +7.75M +134% Aug 6, 2021 10-Q 2021-08-12
Q1 2021 13.5M +10.7M +372% Mar 18, 2021 10-K 2021-03-25
Q3 2020 5.78M -20.6M -78.1% Nov 6, 2020 10-Q 2020-11-10
Q2 2020 5.78M -19.8M -77.4% Aug 7, 2020 10-Q 2020-08-12
Q1 2020 2.87M -19.4M -87.1% Mar 20, 2020 10-K 2020-03-26
Q3 2019 26.4M +8.24M +45.4% Nov 8, 2019 10-Q 2019-11-12
Q2 2019 25.6M +21.2M +487% Aug 9, 2019 10-Q 2019-08-12
Q1 2019 22.3M +19.7M +759% Mar 22, 2019 10-K 2019-03-27
Q3 2018 18.2M -5.53M -23.3% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 4.36M -18.9M -81.2% Aug 10, 2018 10-Q 2018-08-14
Q1 2018 2.59M -19.5M -88.2% Mar 15, 2018 10-K 2018-03-26
Q3 2017 23.7M +17.1M +259% Nov 3, 2017 10-Q 2017-11-08
Q2 2017 23.2M +16.7M +254% Aug 4, 2017 10-Q 2017-08-10
Q1 2017 22M -43.3M -66.3% Mar 15, 2017 10-K 2017-03-30
Q3 2016 6.6M -58.7M -89.9% Nov 4, 2016 10-Q 2016-11-10
Q2 2016 6.56M -58.4M -89.9% Aug 5, 2016 10-Q 2016-08-11
Q1 2016 65.3M +34.1M +109% Mar 15, 2016 10-K 2016-03-30
Q3 2015 65.3M +44.2M +209% Nov 6, 2015 10-Q 2015-11-12
Q2 2015 64.9M +48.8M +303% Aug 7, 2015 10-Q 2015-08-12
Q1 2015 31.2M +17.8M +133% Mar 30, 2015 10-K 2015-03-30
Q3 2014 21.1M +9.45M +80.9% Nov 7, 2014 10-Q 2014-11-13
Q2 2014 16.1M +4.42M +37.8% Aug 8, 2014 10-Q 2014-08-14
Q1 2014 13.4M -308M -95.8% Mar 21, 2014 10-K 2014-03-28
Q3 2013 11.7M -147M -92.6% Nov 12, 2013 10-Q 2013-11-14
Q2 2013 11.7M -146M -92.6% Aug 9, 2013 10-Q 2013-08-14
Q1 2013 322M +179M +126% Mar 15, 2013 10-K 2013-03-29
Q3 2012 159M Nov 9, 2012 10-Q 2012-11-13
Q2 2012 158M Aug 8, 2012 10-Q 2012-08-14
Q1 2012 142M May 10, 2012 10-Q 2012-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.